The effect of intravenous interleukin-2 on brain water content

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 • 600 citations

Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coli

1984 • 600 citations

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2.

1986 • 534 citations

The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells

1987 • 456 citations

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1984 • 299 citations

Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.

1988 • 225 citations

Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma.

1985 • 212 citations

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types.

1986 • 149 citations

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma

1986 • 89 citations

Immunobiology of primary intracranial tumors

1985 • 83 citations

Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier

1988 • 82 citations

Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary report

1977 • 79 citations

In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes

1986 • 76 citations

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion.

1987 • 75 citations

Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice.

1986 • 67 citations

Specific adoptive immunotherapy with tumor-specific cytotoxic T-lymphocyte clone for murine malignant gliomas.

1984 • 64 citations

Clinical studies of intrathecal autologous lymphocyte infusions in patients with malignant glioma: A toxicity study

1978 • 38 citations

Immunobiology of primary intracranial tumors

1981 • 31 citations

Preliminary clinical trial of immunotherapy for malignant glioma.

1987 • 26 citations

The effect of interleukin-2 on the blood-brain barrier in the 9L gliosarcoma rat model

1989 • 25 citations

In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells.

1988 • 20 citations

Motility and tumoricidal activity of interleukin-2-stimulated lymphocytes.

1988 • 17 citations